Glaxo boss gets £8m in rewards

Related articles

• 4 months
  after
  • Glaxo's settlement makes the dividend safer – probably - The Guardian - ...
  • Glaxo takes £1.57bn legal charge - The Guardian - ...
  • FDA scrutinises Glaxo's Avandia - The Guardian - ...
  • Glaxo on red alert as FDA scrutinises diabetes drug Avandia - RecentNews.co.uk
  
  
• 2 months
  after
  • GlaxoSmithKline swine flu sales boost profits - The Guardian - ...
  • FTSE fights back after Greek woes, with oils and Glaxo gaining ground - The Guardian - ...
  
  
• 2 weeks
  after
  • Glaxo shines on Advair news but FTSE edged lower - The Guardian - ...
  
  
• 1 week
  after
  • Time for drug giants to jump into the patent pool? - The Guardian - ...
  • Glaxo could face $6bn Avandia liability, says UBS - The Guardian - ...
  
  
• Selected Article Glaxo boss gets £8m in rewards - City A.M.
• 1 day
  before
  • GlaxoSmithKline issues 30-page defence of its diabetes drug - City A.M.
  
  
• 3 days
  before
  • Glaxo damned by US Senate committee - The Guardian - ...
  • Bunzl boosted by swine flu but Glaxo hit by new Avandia concerns - The Guardian - ...
  
  
• 3 weeks
  before
  • Glaxo to cut more jobs as it aims to slash spending - City A.M.
  • GlaxoSmithKline gets its molecules stabilised | Nils Pratley - The Guardian - ...
  • Glaxo to shed 4,000 jobs as Asia beckons - City A.M.
  
  
• 1 month
  before
  • GSK To Offer Scientists Access To Compounds, Lab Space To Fight Malaria - Medical News Today
  • Swine flu promises GlaxoSmithKline a £1bn boost - The Guardian - ...
  • Nestlé's sale of Alcon fuels speculation - The Guardian - ...
  
  
• 4 months
  before
  • Dose of good news boosts Glaxo - RecentNews.co.uk
  
  
• 5 months
  before
  • Glaxo launches Lucozade in China - The Guardian - ...
  • Glaxo withdraws vomiting drug but Lucozade sparkles in China - The Guardian - ...
  
  
• 7 months
  before
  • Reckitt sales boosted by swine flu fears - The Guardian - ...
  • Glaxo sees confident future ahead - The Guardian - ...
  • Competition from generic drugs hits GSK - The Guardian - ...
  • GSK agrees royalty-free deal on HIV drug - The Guardian - ...